JCB logo
amgmicro.com
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 8 July 2002. doi:10.1083/jcb1581iti3
This Article
Right arrow Full Text (PDF, 389K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dove, A. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dove, A. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/2002/7/9 $5.00
The Journal of Cell Biology, Volume 158, Number 1, July 8, 2002 9-9


In this Issue

Another way to break down


Two pathways must be shut down to prevent ER protein degradation.

When yeast secretory proteins are improperly folded, the ER quality control system directs them into the HRD/DER pathway, which targets the proteins for degradation. Blocking the HRD/DER pathway, however, does not completely stop degradation, implying that there must be an alternative way to destroy misfolded secretory proteins. Haynes et al., reporting on page 91, have now characterized that pathway, and suggest that it may serve to handle the overflow when the HRD/DER system gets swamped.In the HRD/DER pathway, the ubiquitin ligase Hrd1p tags defective proteins, such as a misfolded mutant form of carpoxypeptidase Y (CPY*), for degradation. The authors found that overexpressing CPY* appears to saturate the HRD/DER system, allowing direct observation of the new pathway, named Hrd1p-independent proteolysis (HIP). HIP requires ER-to-Golgi vesicular transport, and uses the ubiquitin ligase Rsp5p instead of Hrd1p.

Blocking both the HRD/DER and HIP pathways completely blocks CPY* degradation, so there do not appear to be any additional pathways for this substrate. Haynes et al. suggest that HRD/DER may be a low-capacity system that handles routine protein-folding problems, whereas HIP could act as a high-capacity system, possibly boosted by the unfolded protein response, to respond when large numbers of proteins are misfolded. {blacksquare}



Alan W. Dove

alanwdove{at}earthlink.net


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 389K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dove, A. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dove, A. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents